︎    ︎    ︎    

Markus Maeurer, MD, PhD, FRCP (London)

Head of the Immunotherapy Programme @Champalimaud Foundation

Lisbon, Portugal

Markus J Maeurer received 1989 his Medical degree at the Johannes Gutenberg University of Mainz, Germany; Research Fellow at the Department of Surgical Oncology, University of Pittsburgh, USA, Assist. Prof of Surgical Oncology and Immunotherapy at UPMC, Pittsburgh, PA, USA. 1999 full Professor of Microbiology and Infectious Diseases at the University of Mainz and and Head of the diagnostic Laboratory at the Department of Medical Microbiology¨2005 Professor of Infectious Diseases, particularly Clinical Immunology, at the Karolinska Institute, at the MTC (Microbiology, Tumor Biology Center).  He served as head of the division Therapeutic Immunology at Karolinska Institute and Senior Physician of the Center for allogeneic stem cell transplantation, CAST, Karolinska Hospital 2012-2017.

Dr. Maeurer is head of immunotherapy / ImmunoSurgery at the Champalimaud Foundation, Lisbon and Prof at the I Medical Clinic of the University of Mainz, Germany, published more than 310 scientific articles, 28 among them in the LANCET series, he created 9 patents, he serves as a reviewer for several international grant agencies and several high impact journals.

Advisor for the Bill and Melinda Gates Foundation, for the UK Parliament and the Italian Government,  Fellow of the Royal Chamber of Physicians, London; initiated with Sir Alimuddin Zumla (UCL, UK) the consortium against cancer and infectious diseases with a particular focus on COVID-19.

Learn more about the speaker here︎︎︎︎

This symposium is supported by QuantOCancer Project funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 810653.